Callan Family Office’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.12M Buy
66,659
+4,225
+7% +$255K 0.08% 230
2026
Q1
$3.65M Buy
62,434
+8,937
+17% +$529K 0.08% 239
2025
Q4
$3.03M Buy
53,497
+25,181
+89% +$1.37M 0.07% 262
2025
Q3
$1.5M Sell
28,316
-2,559
-8% -$139K 0.05% 309
2025
Q2
$1.46M Buy
30,875
+21,931
+245% +$971K 0.05% 321
2025
Q1
$370K Sell
8,944
-4,829
-35% -$190K 0.03% 388
2024
Q4
$500K Buy
+13,773
New +$497K 0.03% 368

Other funds holding BTI

Callan Family Office's BTI Position: Q2 2026 in Review

Callan Family Office increased its British American Tobacco (BTI) stake by 6.8% in Q2 2026, buying an estimated $255K and bringing the position to 66,659 shares worth $4.12M. The position accounts for 0.08% of the portfolio, ranked #230.

Callan Family Office first reported a position in BTI in Q4 2024 and has held it in 7 quarters since. 904 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Callan Family Office held 66,659 shares of British American Tobacco worth $4.12M as of Q2 2026.
  • Callan Family Office bought 4,225 British American Tobacco shares in Q2 2026, an estimated $255K.
  • British American Tobacco made up 0.08% of Callan Family Office's portfolio in Q2 2026, its #230 holding.
  • Callan Family Office first reported a position in British American Tobacco in Q4 2024 and has held it in 7 quarters since.
  • 904 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.